Executive Team

Dr. Richard Knowles, PhD
Dr. Richard Knowles, PhD(President, Chief Psychologist, and Founder)
• MAPS trained psychedelic therapist.
• Over 10 years working in private practice in the Bay area and 4 years working as an adherence rater for MAPS’ MDMA-assisted psychotherapy research for treating PTSD.
• President and Founder of the tax-exempt non-profit, Delos Psyche Research Group (delospsyche.org).
Daniel Mantuani, MD
Daniel Mantuani, MD(Chief Medical Officer, Co-Founder)
• Practicing Emergency Medicine Physician.
• Graduate of Tulane School of Medicine in 2007.
• Ultrasound Fellowship Director at a San Francisco Bay Area Level-1 Trauma public safety net hospital.
Emeline Maillet, CSO
Emeline Maillet, CSO(Chief Science Officer)
• Pending Funding

Team

Paul Abramson, MD
Paul Abramson, MD
Researcher, Trained Psychedelic Therapist, Clinic Owner
Liron van Heerden, BS
Liron van Heerden, BS
Researcher
Alex Holstein, BS
Alex Holstein, BS
Neuropharmacology Researcher

Scientific Advisors

Kelan Thomas, PharmD
Kelan Thomas, PharmD
Associate Professor, Touro UC College of Pharmacy
Adam Halberstadt, PhD
Adam Halberstadt, PhD
Associate Professor, Psychiatry UCSD
Susan Powell, PhD
Susan Powell, PhD
Adjunct Professor, Psychiatry UCSD
Vince Polito, PhD
Vince Polito, PhD
Microdosing Researcher, Professor at Macquarie University
Balvant Sitaram, PhD
Balvant Sitaram, PhD
5-MeO-DMT Researcher, currently retired

DELOS Therapeutics

Manifesting Health, Wellness, and Wonder

“It does not seem to be an exaggeration to say that psychedelics used responsibly and with proper caution, would be for psychiatry what the microscope is for biology and medicine or the telescope is for astronomy.”

Stanislav Grof

DELOS Therapeutics

DELOS Therapeutics is dedicated to rigorously researching and developing psychedelic medicines with the aim of producing commercially available treatments that are safe, effective, and affordable.

Contact Us